Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Full Prescribing Information, Copaxone (glatiramer acetate)
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Timing of birth and risk of multiple sclerosis: population based study.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Glial cells as drug targets: What does it take?
Drugs@FDA
Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
UCSF Seminar: "MRI of Lesion Development and Repair in Multiple Sclerosis"
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Autoimmune myelopathies.
UCSF Seminar: "Imaging spinal cord gray matter atrophy in MS using SF-SIGMA. Is neuronal loss a key mediator of MS disability?"
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Management of women with multiple sclerosis through pregnancy and after childbirth.
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Effects of dimethyl fumarate on lymphocyte subsets.
Alpha/beta interferon is a neuronal growth factor.
Rituximab for relapsing-remitting multiple sclerosis.
Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.

Pages